Can contemporary patients with biopsy Gleason score 3 4 be eligible for active surveillance? (Q28543448)

2

0 references

In Jae Lee

3

0 references

Seok-Soo Byun

4

0 references

Sang Eun Lee

5

0 references

Sung Kyu Hong

Creative Commons Attribution 4.0 International

6

0 references

language of work or name

English

0 references

publication date

2014

0 references

published in

PLOS One

0 references

volume

9

0 references

issue

9

0 references

page(s)

e109031

0 references

copyright license

start time

30 September 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Prostate volume and biopsy tumor length are significant predictors for classical and redefined insignificant cancer on prostatectomy specimens in Japanese men with favorable pathologic features on biopsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182658

Can MRI replace serial biopsies in men on active surveillance for prostate cancer?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182658

Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance Study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182658

Medium-term outcomes of active surveillance for localised prostate cancer.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182658

Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182658

Outcomes of active surveillance for men with intermediate-risk prostate cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182658

Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182658

The association between prostate size and Gleason score upgrading depends on the number of biopsy cores obtained: results from the Shared Equal Access Regional Cancer Hospital Database

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182658

The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182658

Early outcomes of active surveillance for localized prostate cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182658

An analysis of men with clinically localized prostate cancer who deferred definitive therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182658

Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182658

Comparison of percentage of total prostate needle biopsy tissue with cancer to percentage of cores with cancer for predicting PSA recurrence after radical prostatectomy: results from the SEARCH database

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4182658

Pathologic prostate cancer characteristics in patients eligible for active surveillance: a head-to-head comparison of contemporary protocols.

3 June 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0109031

Active Surveillance Program for Prostate Cancer: An Update of the Johns Hopkins Experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0109031

Active surveillance for low-risk prostate cancer worldwide: the PRIAS study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0109031

Careful Selection and Close Monitoring of Low-Risk Prostate Cancer Patients on Active Surveillance Minimizes the Need for Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0109031

The relationship between prostate specific antigen change and biopsy progression in patients on active surveillance for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0109031

Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0109031

Outcomes of initially expectantly managed patients with low or intermediate risk screen-detected localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0109031

Prostate size as a predictor of Gleason score upgrading in patients with low risk prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0109031

Prostate specific antigen density to predict prostate cancer upgrading in a contemporary radical prostatectomy series: a single center experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0109031

Prediction of Indolent Prostate Cancer: Validation and Updating of a Prognostic Nomogram

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0109031

Percentage of cancer involvement in positive cores can predict unfavorable disease in men with low-risk prostate cancer but eligible for the prostate cancer international: active surveillance criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0109031

Clinical utility of a biopsy-based cell cycle gene expression assay in localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0109031

Validation of a cell-cycle progression gene panel to improve risk stratification in a contemporary prostatectomy cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0109031

Active surveillance for prostate cancers detected in three subsequent rounds of a screening trial: characteristics, PSA doubling times, and outcome

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25268898

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25268898

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Predictors of unfavorable disease after radical prostatectomy in patients at low risk by D'Amico criteria: role of multiparametric magnetic resonance imaging

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25268898